Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 6, 2008, Pages

  Strunk, Robert C ^a   Bacharier, Leonard B ^a   Phillips, Brenda R ^b   Szefler, Stanley J ^e   Zeiger, Robert S ^c,d   Chinchilli, Vernon M ^b   Martinez, Fernando D ^f   Lemanske Jr , Robert F ^g   Taussig, Lynn M ^e   Mauger, David T ^b   Morgan, Wayne J ^f   Sorkness, Christine A ^h   Paul, Ian M ^b   Guilbert, Theresa ^g   Krawiec, Marzena ^e   Covar, Ronina ^e   Larsen, Gary ^e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d KAISER PERMANENTE   (United States)

^e NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^h U of WI School of Pharmacy   (United States)

Author keywords

Asthma; children; clinical trial; leukotriene receptor antagonist; macrolide; moderate to severe

Indexed keywords

AZITHROMYCIN; BUDESONIDE; CORTICOSTEROID; MONTELUKAST; PLACEBO; SALMETEROL;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 57149124346     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.09.028     Document Type: Article

References (22)

1. Moore W., and Peters S. Severe asthma: an overview. J Allergy Clin Immunol 117 (2006) 487-494
2. Ball B., Hill M., Brenner M., Sanks R., and Szefler S. Effect of low-dose troleandomycin on glucocorticoid kinetics and airway hyperresponsiveness in severely asthmatic children. Ann Allergy 65 (1990) 37-45
3. Kamada A., Hill M., Iklé D., Brenner A., and Szefler S. Efficacy and safety of troleandomycin therapy in severe, steroid-requiring asthmatic children. J Allergy Clin Immunol 91 (1993) 873-882
4. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report. Guidelines for the diagnosis and management of asthma-update on selected topics 2002 (2002), National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda
5. National Asthma Education and Prevention Program expert panel report. Expert panel report 3: guidelines for the diagnosis and management of asthma (2007), Department of Health and Human Services, Bethesda
6. Visser M., van der Veer E., Postma D., Arends L., de Vries T., Brand P., et al. Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J 24 (2004) 420-425
7. Kostadima E., Tsiodras S., Alexopoulos E., Kaditis A., Mavrou I., Georgatou N., et al. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma. Eur Respir J 23 (2004) 714-717
8. Black P., Blasi F., Jenkins C., Scicchitano R., Mills G., Rubinfeld A., et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 164 (2001) 536-541
9. Jaffe A., and Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol 31 (2001) 464-473
10. Oda H., Kadota J., Kohno S., and Hara K. Erthromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchilits. Chest 49 (1994) 1116-1123
11. Saiman L., Marshall B., Mayer-Hamblett N., Burns J., Quittner A., Cibene D., et al. Azithromycin in patients with cystic fibrosis chronically infected with pseudomonas aeruginosa: a randomized controlled trial. JAMA 290 (2003) 1749-1756
12. Johnston N., Mandhane P., Dai J., Duncan J., Greene J., Lambert K., et al. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 120 (2007) e702-e712
13. Lofdahl C., Reiss T., Leff J., Israel E., Noonan M., Finn A., et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ 319 (1999) 87-90
14. Simons F.E., Villa J.R., Lee B.W., Teper A.M., Lyttle B., Aristizabal G., et al. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. J Pediatr 138 (2001) 694-698
15. Lemanske R.J., Sorkness C., Mauger E., Lazarus S., Boushey H., Fahy J., et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 285 (2001) 2594-2603
16. Fost D., Leung D., Martin R., Brown E., Szefler S., and Spahn J. Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. J Allergy Clin Immunol 103 (1999) 1031-1035
17. United States Pharmacopeial Convention, I. Dissolution (2005), The United States Pharmacopeia/the National Formulary (USP 28/NF 23), Rockville (MD) 2412-5
18. Jones C., Clement L., Morphew T., Kwong K., Hanley-Lopez J., Lifson F., et al. Achieving and maintaining asthma control in an urban pediatric disease management program: the Breathmobile Program. J Allergy Clin Immunol 119 (2007) 1445-1453
19. Biscione G., Corne J., Chauhan A., and Johnston S. Increased frequency of detection of Chlamydophila pneumoniae in asthma. Eur Respir J 24 (2004) 745-749
20. Gencay M., Rudiger J., Tamm M., Soler M., Prruchoud A., and Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med 163 (2001) 1097-1100
21. Biscardi S., Lorrot M., Marc E., Moulin F., Boutonnat-Faucher B., Heilbronner C., et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 38 (2004) 1341-1346
22. McCoy K., Shade D., Irvin C., Mastronarde J., Hanania N., Castro M., et al. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol 118 (2006) 1226-1233